This is a long-term extension trial to study the safety and tolerability of continued
setmelanotide treatment in patients who have completed a previous clinical trial on treatment
with setmelanotide for obesity associated with genetic defects upstream of the MC4 receptor
in the leptin-melanocortin pathway.